MOLECULAR DOCKING OF ALPHA-AMYLASE BY REPURPOSING                                                                                                     FDA APPROVED DRUGS 1 Dr. Iqra Ahmad (Biochemistry) 2 Dr. Muhammad Naeem (Business Administration) Laureate Folks International https://laureatefolks.blogspot.com laureatefolks@gmail.com , WhatsApp: +923334446261   1            INTRODUCTION Diabetes mellitus type 2 (T2DM) is non-insulin-dependent diabetes mellitus characterized by increased blood glucose concentration and it is one of the most prevalent metabolic disorders. Almost 1 in 10 people are suffering from T2DM and it is a cause of obesity as well. There are several studies for the treatment of T2DM and some of them have drawbacks. This study aims to find a potential inhibitor for alpha-amylase as it directly participates in the formation of glucose from food. FDA-approved drugs will be screened in this study against alpha-amylase for r